Abivax ABVX
NASDAQ ABVX
$90.23 -3.26 (-3.49%)
At close: Oct 22, 2026 · 4:00 PM EDT

Abivax (ABVX) Price to Sales (2024 - 2025)

Updated

Analysis

Abivax (ABVX) Price to Sales (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Abivax 6.26 Bn 3.90 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 44.01
Jun 30, 2025 23.09
Mar 31, 2025 16.01
Dec 31, 2024 15.56
API Access

Abivax Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ABVX&period=max&api_key=YOUR_API_KEY